The use of B vitamins for cutaneous ulcerations mimicking pyoderma gangrenosum in patients with MTHFR polymorphism

Douglas New1, Philip Eaton, Al Knable

  • 1Division of Dermatology, University of Louisville, Louisville, KY 40202, USA.

Abstract

Insights

Methylenetetrahydrofolate reductase (MTHFR) gene variations can cause blood clotting issues leading to skin ulcers. Supplementing with B vitamins (folic acid, B6, B12) may help heal these ulcers in patients with MTHFR mutations.

Area of Science:

  • Genetics
  • Dermatology
  • Hematology

Background:

  • Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms are linked to thrombophilia and vasculopathy, potentially causing skin ulcerations.
  • Pyoderma gangrenosum (PG) is diagnosed after excluding other causes of ulcers, such as vascular disease, infection, or cancer.

Observation:

  • Two patients with MTHFR polymorphisms presented with lower extremity cutaneous ulcerations during hypercoagulable workup.
  • Both patients experienced rapid improvement with oral vitamin supplementation (B9, B6, B12) and local wound care.
  • One patient's ulcers recurred upon discontinuing therapy, healing again after reinitiation, with no adverse effects.

Findings:

  • MTHFR polymorphisms are associated with recurrent cutaneous ulcerations.
  • Vitamin supplementation (folic acid, B6, B12) can effectively treat ulcers in patients with MTHFR mutations.
  • Treatment with B vitamins was well-tolerated.

Implications:

  • MTHFR gene testing should be considered in hypercoagulable evaluations for unexplained skin ulcers.
  • Vitamin B supplementation offers a potential therapeutic strategy for MTHFR-associated cutaneous ulcerations.
  • This highlights the link between genetic factors, coagulation, and dermatological conditions.

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...